Scientists are actively researching alternatives to traditional antibiotics. These include phage therapy (using viruses that target and destroy specific bacteria), vaccines to prevent infections before they start, and gene-editing technologies like CRISPR to disable resistance mechanisms within bacterial DNA. Conclusion
The growing global threat of antibiotic resistance requires immediate, coordinated action. Addressing this issue requires: of antibiotic prescriptions. Reduction of antibiotic use in agriculture. Addressing this issue requires: of antibiotic prescriptions
Keeping new breakthrough antibiotics as a "last resort" has financial disadvantages for pharmaceutical corporations. The text suggests that a multifaceted approach is
The text suggests that a multifaceted approach is needed, including improving antibiotic stewardship, enhancing surveillance and monitoring of antibiotic use and resistance, and promoting the development of new antibiotics. which patients take daily for decades
Through natural selection and rapid reproduction, bacteria that survive exposure to an antibiotic pass on their resistance genes to offspring.
For pharmaceutical companies, the return on investment (ROI) for antibiotics is notoriously low. Unlike chronic medications for hypertension or diabetes, which patients take daily for decades, antibiotics are short-course curative drugs used for a week or two. Furthermore, when a breakthrough antibiotic is discovered, medical guidelines dictate that it should be kept on the shelf as a "last resort" to prevent bacteria from developing resistance to it. Consequently, sales volumes remain low. This economic reality has driven major pharmaceutical firms out of antibiotic research, leaving the field dangerously underfunded. Combating the Threat: A Unified Approach
: Paragraph C identifies "lax regulatory frameworks, allowing powerful broad-spectrum antibiotics to be purchased over the counter without a qualified medical prescription." 7. evolutionary mechanism